Ilet Bionic Pancreas
Payments companies reported to CMS as associated with Ilet Bionic Pancreas. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ilet Bionic Pancreas, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ilet Bionic Pancreas
These are the largest totals companies reported as associated with Ilet Bionic Pancreas. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Bantwal Baliga | Opelika, AL | Endocrinology, Diabetes & Metabolism | $8,667.39 |
| Bruce Bode | Atlanta, GA | Endocrinology, Diabetes & Metabolism | $6,592.17 |
| Bantwal Baliga | Columbus, GA | Family Medicine | $5,425.44 |
| Seema Ahluwalia | Chandler, AZ | Endocrinology, Diabetes & Metabolism | $3,608.52 |
| Kalpana Reddy | Flushing, NY | Endocrinology, Diabetes & Metabolism | $3,589.41 |
| Ashlea Hill | Ruston, LA | Family | $3,415.89 |
| Yshay Shlesinger | San Ramon, CA | Internal Medicine | $3,153.42 |
| Daniel Tung | Houston, TX | Endocrinology, Diabetes & Metabolism | $3,069.24 |
| Kecia Ford | East Meadow, NY | Internal Medicine | $3,062.61 |
| Rocio Harbison | Houston, TX | Endocrinology, Diabetes & Metabolism | $2,946.90 |
Prescribed Ilet Bionic Pancreas?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.